# EXPAREL for Minimally Invasive Supracervical Hysterectomies

> **NCT03769714** · PHASE4 · COMPLETED · sponsor: **Maimonides Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Saline Solution for Injection
- **DRUG:** Exparel

## Key facts

- **NCT ID:** NCT03769714
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769714, "EXPAREL for Minimally Invasive Supracervical Hysterectomies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03769714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*